VAV1 and multiple sclerosis: Taken together, the data presented in this work suggest that the use of inhibitors for the catalytic activity of Vav1 could represent a viable alternative to reduce the degenerative processes associated with rheumatoid arthritis and related diseases, such as multiple sclerosis, at least in their most incipient states.